# GLYRX-PF

NDC: 51754-6000
Generic name: glycopyrrolate
Labeler / Manufacturer: Exela Pharma Sciences, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20180801

FDA application: NDA210997

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51754-6000"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51754-6000
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2189f3f5-39dc-4e85-b7c6-9515ded59686